H Jonuleit

Summary

Affiliation: University of Mainz
Country: Germany

Publications

  1. ncbi Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells
    Helmut Jonuleit
    Department of Dermatology, University of Mainz, 55101 Mainz, Germany
    J Exp Med 196:255-60. 2002
  2. ncbi CD4-mediated functional activation of human CD4+CD25+ regulatory T cells
    Christian Becker
    Department of Dermatology, Johannes Gutenberg University, Mainz, Germany
    Eur J Immunol 37:1217-23. 2007
  3. ncbi A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection
    H Jonuleit
    Department of Dermatology, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany
    Int J Cancer 93:243-51. 2001
  4. ncbi The regulatory T cell family: distinct subsets and their interrelations
    Helmut Jonuleit
    Department of Dermatology, Johannes Gutenberg-University, Mainz, Germany
    J Immunol 171:6323-7. 2003
  5. ncbi Induction of tumor peptide-specific cytotoxic T cells under serum-free conditions by mature human dendritic cells
    H Jonuleit
    Department of Dermatology, University of Mainz, Germany
    Arch Dermatol Res 292:325-32. 2000
  6. ncbi Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
    H Jonuleit
    Department of Dermatology, University of Mainz, D 55101 Mainz, Germany
    J Exp Med 192:1213-22. 2000
  7. ncbi Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood
    H Jonuleit
    Department of Dermatology, University of Mainz, D 55101 Mainz, Germany
    J Exp Med 193:1285-94. 2001
  8. ncbi Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions
    H Jonuleit
    Department of Dermatology, University of Mainz, Germany
    Eur J Immunol 27:3135-42. 1997
  9. ncbi Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells
    K Steinbrink
    Department of Dermatology, University of Mainz, Mainz, Germany and the Department of Dermatology, University of Erlangen, Erlangen, Germany
    Blood 93:1634-42. 1999
  10. ncbi Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins
    K Steinbrink
    Department of Dermatology, University of Mainz, Langenbeckstr 1, 55131 Mainz, Germany
    Arch Dermatol Res 292:437-45. 2000

Collaborators

Detail Information

Publications35

  1. ncbi Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells
    Helmut Jonuleit
    Department of Dermatology, University of Mainz, 55101 Mainz, Germany
    J Exp Med 196:255-60. 2002
    ..This explains previously published conflicting data on the role of TGF-beta in CD25(+) Treg cell-induced immunosuppression...
  2. ncbi CD4-mediated functional activation of human CD4+CD25+ regulatory T cells
    Christian Becker
    Department of Dermatology, Johannes Gutenberg University, Mainz, Germany
    Eur J Immunol 37:1217-23. 2007
    ..These results identify CD4 as a trigger for the suppressive function of CD25(+) Tregs and suggest a possible CD4-mediated exploitation of these cells...
  3. ncbi A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection
    H Jonuleit
    Department of Dermatology, University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany
    Int J Cancer 93:243-51. 2001
    ..Thus, our data define FCS-free cultured mature DCs as superior inducers of T-cell responses in melanoma patients...
  4. ncbi The regulatory T cell family: distinct subsets and their interrelations
    Helmut Jonuleit
    Department of Dermatology, Johannes Gutenberg-University, Mainz, Germany
    J Immunol 171:6323-7. 2003
  5. ncbi Induction of tumor peptide-specific cytotoxic T cells under serum-free conditions by mature human dendritic cells
    H Jonuleit
    Department of Dermatology, University of Mainz, Germany
    Arch Dermatol Res 292:325-32. 2000
    ..These data show that terminally differentiated mature DC are necessary for the induction of tumor antigen-specific CTL responses...
  6. ncbi Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
    H Jonuleit
    Department of Dermatology, University of Mainz, D 55101 Mainz, Germany
    J Exp Med 192:1213-22. 2000
    ..These data show that immature and mature DCs induce different types of T cell responses: inflammatory Th1 cells are induced by mature DCs, and IL-10-producing T cell regulatory 1-like cells by immature DCs...
  7. ncbi Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood
    H Jonuleit
    Department of Dermatology, University of Mainz, D 55101 Mainz, Germany
    J Exp Med 193:1285-94. 2001
    ..However, the refractory state of CD4(+)CD25(+) T cells was partially reversible by the addition of IL-2 or IL-4. These data demonstrate that human blood contains a resident T cell population with potent regulatory properties...
  8. ncbi Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions
    H Jonuleit
    Department of Dermatology, University of Mainz, Germany
    Eur J Immunol 27:3135-42. 1997
    ..TNF-alpha/IL-1, IL-6 + PGE2-cultured DC seem to be optimal for generation of IFN-gamma-producing CD4/CD8+ T cells...
  9. ncbi Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells
    K Steinbrink
    Department of Dermatology, University of Mainz, Mainz, Germany and the Department of Dermatology, University of Erlangen, Erlangen, Germany
    Blood 93:1634-42. 1999
    ....
  10. ncbi Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins
    K Steinbrink
    Department of Dermatology, University of Mainz, Langenbeckstr 1, 55131 Mainz, Germany
    Arch Dermatol Res 292:437-45. 2000
    ..Collectively, our data show that members of the PG family promote the differentiation of DC and enhance their capacity to induce a Th1 immune response...
  11. ncbi Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells
    B Schuler-Thurner
    Department of Dermatology, University of Erlangen Nuremberg, Erlangen, Germany
    J Immunol 165:3492-6. 2000
    ..Therefore, our DC vaccination strategy performs an adjuvant role and encourages further optimization of this new immunization approach...
  12. ncbi Priming of T cells with Ad-transduced DC followed by expansion with peptide-pulsed DC significantly enhances the induction of tumor-specific CD8+ T cells: implications for an efficient vaccination strategy
    A Tuettenberg
    Department of Dermatology, J. Gutenberg-University, Langenbeckstrasse 1, D-55101 Mainz, Germany
    Gene Ther 10:243-50. 2003
    ..Based on these data, we suggest a prime/boost vaccination strategy in melanoma patients--combining the use of Ad-DC and peptide-pulsed DC--to obtain efficient and long-term antitumor T-cell responses...
  13. ncbi Dendritic cells as a tool to induce anergic and regulatory T cells
    H Jonuleit
    Dept of Dermatology, University of Mainz, Langenbeckstr 1, D 55131 Mainz, Germany
    Trends Immunol 22:394-400. 2001
    ..What is the current state of knowledge of the "immunoregulatory" properties of dendritic cells and how might tolerance-inducing dendritic cells be relevant to therapeutic applications in humans?..
  14. ncbi Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients
    Andrea Tuettenberg
    Department of Dermatology, Johannes Gutenberg-University, Langenbeckstrasse 1, D-55101 Mainz, Germany
    Int J Cancer 118:2617-27. 2006
    ....
  15. ncbi Early adenoviral gene expression mediates immunosuppression by transduced dendritic cell (DC): implications for immunotherapy using genetically modified DC
    Andrea Tuettenberg
    Department of Dermatology, J. Gutenberg-University, Mainz, Germany
    J Immunol 172:1524-30. 2004
    ..These results have important implications for the use of genetically modified DC for therapeutic application...
  16. ncbi Generation of monoclonal antibodies against human regulatory T cells
    Christian Becker
    Department of Dermatology of University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstrasse1, 55101 Mainz, Germany
    J Immunol Methods 353:62-70. 2010
    ....
  17. ncbi CD40 signalling induces IL-10-producing, tolerogenic dendritic cells
    Andrea Tuettenberg
    Department of Dermatology, Johannes Gutenberg University, Mainz, Germany
    Exp Dermatol 19:44-53. 2010
    ..These data demonstrate that DC stimulated through CD40-CD40L interaction differentiate into tolerogenic DC with immunomodulatory function...
  18. ncbi Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells
    Christian Becker
    Department of Dermatology, Johannes Gutenberg University, Mainz, Germany
    Blood 114:1263-9. 2009
    ..Our findings demonstrate that stimulation via the CD4 receptor represents a T-cell receptor-independent Treg activating pathway with potential to induce immunologic tolerance in vivo...
  19. ncbi The role of ICOS in directing T cell responses: ICOS-dependent induction of T cell anergy by tolerogenic dendritic cells
    Andrea Tuettenberg
    Department of Dermatology, University of Mainz, Mainz, Germany
    J Immunol 182:3349-56. 2009
    ..Taken together, these results indicate a crucial role for ICOS in the induction of peripheral tolerance maintained by tolerogenic DC mediated mostly via an IL-10-independent mechanism...
  20. ncbi Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance?
    Kerstin Steinbrink
    Department of Dermatology, Johannes Gutenberg University Mainz, Mainz, Germany
    Hum Immunol 70:289-93. 2009
    ....
  21. ncbi Dendritic cell-based immunotherapy of malignant melanoma: success and limitations
    Andrea Tuettenberg
    Department of Dermatology, Johannes Gutenberg University, Mainz, Germany
    J Dtsch Dermatol Ges 5:190-6. 2007
    ..These studies open a new way for "conditioning" of DC by TLRL and might significantly enhance the efficiency of DC-based melanoma vaccines in the future...
  22. ncbi Oxymetazoline modulates proinflammatory cytokines and the T-cell stimulatory capacity of dendritic cells
    Andrea Tuettenberg
    Department of Dermatology, University of Mainz, Mainz, Germany
    Exp Dermatol 16:171-8. 2007
    ..Therefore, the therapeutic benefit of OMZ can be explained in part by its immunomodulating effects in the topical treatment of nasal inflammation...
  23. ncbi Immature, but not inactive: the tolerogenic function of immature dendritic cells
    Karsten Mahnke
    Department of Dermatology and Institute of Immunology, University of Mainz, Germany
    Immunol Cell Biol 80:477-83. 2002
    ..This review summarizes the current knowledge about the immunoregulatory role of immature DC that might act as guardians for the induction and maintenance of T cell tolerance in the periphery...
  24. ncbi Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells
    Michael Stassen
    Institute of Immunology, Johannes Gutenberg-University, Mainz, Germany
    Eur J Immunol 34:1303-11. 2004
    ....
  25. ncbi Dendritic cells: sentinels of immunity and tolerance
    Jan Kubach
    Department of Dermatology, University of Mainz, Germany
    Int J Hematol 81:197-203. 2005
    ..This brief review summarizes the current knowledge about the immunoregulatory role of DC as guardians for the induction of T-cell immunity and tolerance...
  26. ncbi Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: superiority of HSP60
    Karen Bethke
    First Department of Internal Medicine and Department of Dermatology, , Mainz, Germany
    J Immunol 169:6141-8. 2002
    ..These findings show that HSP can differ considerably in the capacity to activate monocyte-derived APC under certain conditions and underline the potential of HSP60 and HSP72 as activation signals for the innate immune system...
  27. ncbi Regulatory T-cells in antitumor therapy: isolation and functional testing of CD4+CD25+ regulatory T-cells
    Helmut Jonuleit
    Department of Dermatology, , Mainz, Germany
    Methods Mol Med 109:285-96. 2005
    ..Additionally, co-culture assays for functional characterization of isolated CD4+CD25+ regulatory T-cells are described that are able to detect their suppressive properties for conventional CD4+ T-cells with high sensitivity...
  28. ncbi Regulatory T cells--the renaissance of the suppressor T cells
    Tobias Bopp
    Department of Dermatology, Johannes Gutenberg University, Mainz, Germany
    Ann Med 39:322-34. 2007
    ..Herein, we give a comprehensive review about this research on T regulatory cells and the relevance of this suppressive T cell population for the development of innovative immune therapeutic strategies...
  29. ncbi Human CD(4+)CD(25+) regulatory T cells and infectious tolerance
    Michael Stassen
    Institute of Immunology, Johannes Gutenberg University, Mainz, Germany
    Transplantation 77:S23-5. 2004
    ..Thus, our findings reconcile contradictory results clearly demonstrating that suppression is contact dependent in vitro but mediated by soluble factors (IL-10 and TGF-beta) in vivo...
  30. ncbi Immune regulation by regulatory T cells: implications for transplantation
    Helmut Jonuleit
    Department of Dermatology, University of Mainz, Hochhaus am Augustusplatz, Langenbeckstr. 1, 55101 Mainz, Germany
    Transpl Immunol 11:267-76. 2003
    ..This review summarises the current knowledge regarding the immunoregulatory role of dendritic cells and the functional activities of resident regulatory T cells as guardians for peripheral T cell tolerance...
  31. ncbi Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function
    Jan Kubach
    Department of Dermatology, Johannes Gutenberg University, Mainz, Germany
    Blood 110:1550-8. 2007
    ..Notably, first identified here as expressed in human T lymphocytes, galectin-10 is essential for the functional properties of CD25(+) Treg cells...
  32. ncbi Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses
    Tobias Warger
    Institute of Immunology, University of Mainz, Obere Zahlbacherstrasse 67, 55131 Mainz, Germany
    J Biol Chem 281:22545-53. 2006
    ....
  33. ncbi ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells
    Esther J Witsch
    Molecular Immunology, Robert Koch Institute, Berlin, Germany
    Eur J Immunol 32:2680-6. 2002
    ..Our data thus indicate a selective regulation of IL-10 secretion by ICOS on re-activation of effector T cells with professional antigen-presenting cells (bearing CD80 and CD86) in lymphoid tissue...
  34. ncbi Differential regulatory capacity of CD25+ T regulatory cells and preactivated CD25+ T regulatory cells on development, functional activation, and proliferation of Th2 cells
    Michael Stassen
    Institute of Immunology, Johannes Gutenberg University, Hochhaus am Augustusplatz, D-55101 Mainz, Germany
    J Immunol 173:267-74. 2004
    ..Hence, our study indicates that CD25+ Treg cells have a therapeutic potential for Th2-mediated diseases and suggests a novel mechanism of suppression mediated by the transcriptional repressor FoxP3...
  35. ncbi Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression
    Tobias Bopp
    Institute for Immunology, Johannes Gutenberg University, 55131 Mainz, Germany
    J Exp Med 204:1303-10. 2007
    ..Hence, naturally occurring T reg cells unexpectedly may control the immune regulatory network by a well-known mechanism based on the intercellular transport of cAMP via gap junctions...